Marion Leboyer and Corinne Haioun among the 2023 Best Female Scientists in the World

Published on January 24, 2024

The 2023 edition of Research.com’s ranking of the best female scientists in the world has been published. The ranking celebrates the work of female researchers and increases their visibility. It uses data acquired from a wide range of bibliometric sources on a panel of 166,880 profiles.

Best Female Scientists
Best Female Scientists

The second edition of Research.com’s ranking has put two of UPEC’s professors among the top 30 best female scientists in France in 2023. The ranking includes first-rate researchers in all areas of study.

Marion Leboyer

Marion Leboyer is a psychiatrist and has been a researcher at INSERM since 1986. Since 2007, she has been co-directing the Translational Neuropsychiatry Laboratory at the Mondor Institute for Biomedical Research (IMRB). The laboratory has three locations: the Henri-Mondor Hospital and the Albert-Chenevier Hospital, both of which are in Créteil, and at NeuroSpin within the French Alternative Energies and Atomic Energy Commission (CEA) in Saclay. Her work in psychiatry focuses on a plethora of heterogenous pathologies, which require the use of a variety of tools from many areas such as genetics, immunology, brain imaging, and epidemiology.

Marion Leboyer also won the Inserm Grand Prize in 2021 for her innovative work on bipolar disorders, schizophrenia, and autism spectrum disorder.

Corinne Haioun

Corinne Haioun, a university professor and hospital practitioner in hematology at the Henri-Mondor University Hospital in Créteil, also stood out in the ranking of top female researchers in France. Corinne Haioun is one of the expert pathologists in the Lymphopath network, which tracks the number of lymphomas in the country. She is responsible for the Hematological Disorders Unit at the Henri-Mondor Hospital in Créteil. She also sits on the board of the Lymphoma Study Association (LYSA), an independent network that conducts clinical research on lymphomas and leads clinical studies ranging from preliminary tests on new treatments for human patients, to the creation of leading therapeutic strategies.